A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate‐1 risk myelodysplastic syndromeAzra Raza, Mikkael A. Sekeres, Ralph V. Boccia et al.|Cancer|2011Cited by 44
Phase 2 Randomized Multicenter Study of Extended Dosing Schedules of Oral Ezatiostat HCl (Telintra), a Glutathione Analog Prodrug GSTP1-1 Inhibitor, In Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)Azra Raza, Mikkael A. Sekeres, Naomi Galili et al.|Blood|2010Cited by 2